Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis in Remission”

Showing 13 of 0 results

Not applicableUnknownNCT03365856
What this trial is testing

Remission in Rheumatoid Arthritis in the Asian-Pacific Region

Who this might be right for
Rheumatoid Arthritis
Peking University People's Hospital 1,500
Post-approval studies (Phase 4)Ended earlyNCT01602302
What this trial is testing

Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Medical University of Graz 40
Not applicableStudy completedNCT02531061
What this trial is testing

Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy

Who this might be right for
Rheumatoid Arthritis
Centre Hospitalier Universitaire de Saint Etienne 35
Not applicableStudy completedNCT01649817
What this trial is testing

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 183
Post-approval studies (Phase 4)Ended earlyNCT01251120
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 2
Post-approval studies (Phase 4)Not Yet RecruitingNCT07582185
What this trial is testing

Tdose Binding and Tocilizumab

Who this might be right for
Rheumatoid Arthritis
Centre Hospitalier Universitaire de Nice 122
Not applicableUnknownNCT04429776
What this trial is testing

Tapering of Biologics in Inflammatory Arthritis Patients in Remission

Who this might be right for
Rheumatoid ArthritisPsoriatic Arthritis
University of Manchester 51
Large-scale testing (Phase 3)UnknownNCT02779114
What this trial is testing

RETRO (REduction of Therapy in RA Patients in Ongoing Remission)

Who this might be right for
Rheumatoid Arthritis
University of Erlangen-Nürnberg Medical School 318
Post-approval studies (Phase 4)Study completedNCT04157010
What this trial is testing

Tocilizumab REMission in Early RA

Who this might be right for
Rheumatoid Arthritis
University of Leeds 20
Post-approval studies (Phase 4)Study completedNCT02198651
What this trial is testing

Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

Who this might be right for
Rheumatoid ArthritisMusculoskeletal and Connective Tissue Diseases
AbbVie 149
Testing effectiveness (Phase 2)Study completedNCT02293590
What this trial is testing

RICE: Remission by Intra-articular Injection Plus CErtolizumab

Who this might be right for
Rheumatoid Arthritis
Rüdiger B. Müller 43
Large-scale testing (Phase 3)Study completedNCT01034137
What this trial is testing

Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 317
Not applicableLooking for participantsNCT07678112
What this trial is testing

Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy

Who this might be right for
Rheumatoid Arthritis (RA)
Francisco J. Blanco 184

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation